Dr. Sundby is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
9000 Rockville Pike, Building 10-CRC
Bethesda, MD 20814Phone+1 240-858-3847
Education & Training
- National Cancer InstituteFellowship, Pediatric Hematology/Oncology, 2017
- Johns Hopkins UniversityFellowship, Pediatric Hematology/Oncology, 2017 - 2021
- University of California San FranciscoPediatrics, Residency, 2014 - 2017
- Vanderbilt University School of MedicineClass of 2014, MD
- Haverford CollegeBS, Biology, 2004 - 2008
Certifications & Licensure
- MD State Medical License 2018 - 2025
- CA State Medical License 2016 - 2018
- American Board of Pediatrics Pediatrics
- American Board of Pediatrics Pediatric Hematology-Oncology
Awards, Honors, & Recognition
- Omolara A. Olaniyan, MD Fellowship Appreciation Award for Teaching and Patient Care John Hopkins, 2018
- Medical Scholar Vanderbilt University, 2012
Publications & Presentations
PubMed
- 35 citationsCell-free DNA ultra-low-pass whole genome sequencing to distinguish malignant peripheral nerve sheath tumor (MPNST) from its benign precursor lesion: A cross-sectional...Jeffrey J. Szymanski, R. Taylor Sundby, Paul Jones, Divya Srihari, Noah Earland
Plos Medicine. 2021-08-31 - 17 citationsUrine cell-free DNA multi-omics to detect MRD and predict survival in bladder cancer patients.Pradeep S Chauhan, Alexander Shiang, Irfan Alahi, R Taylor Sundby, Wenjia Feng
NPJ Precision Oncology. 2023-01-19 - 3 citationsA Phase II Trial of Guadecitabine in Children and Adults with SDH-Deficient GIST, Pheochromocytoma, Paraganglioma, and HLRCC-Associated Renal Cell Carcinoma.John A Ligon, R Taylor Sundby, Mary F Wedekind, Fernanda I Arnaldez, Jaydira Del Rivero
Clinical Cancer Research. 2023-01-17
Abstracts/Posters
- Cell free DNA analysis for early detection of malignant transformation in patients with neurofibromatosis type 1 (NF1)R. Taylor Sundby, MD, Children’s Tumor Foundation NF Conference, Virtual, 2020
- Genetic and epigenetic determinants of breast cancerR. Taylor Sundby, Certificate Program in Molecular Medicine Symposium, Vanderbilt-Ingram Cancer Center Retreat and Medical Scholars Research Day, Nashville, TN, 2013
- Normal human islets form amyloid in vitro and in vivoR. Taylor Sundby, NIDDK Medical Student Research National Symposium, Nashville, TN, 2010
- Join now to see all
Lectures
- Applications of cell free DNA in cancer predisposition (Branch Rounds)National Cancer Institute: Division of Cancer Epidemiology and Genetics, Bethesda, MD - 2020
- Updates on Immune Thrombocytopenic Purpura (Johns Hopkins Pediatric Trends, Invited Speaker)Baltimore, MD - 2019
- Investigative and Clinical Applications of Cell Free DNA (Branch Rounds)National Institute of Diabetes and Kidney Diseases: Metabolic Diseases Branch, Bethesda, MD - 2019
Other Languages
- Spanish
External Links
- Faculty Profilehttps://ccr.cancer.gov/staff-directory/russell-taylor-sundby
- Orcidhttps://orcid.org/0000-0001-8485-0026
- LinkedInhttps://www.linkedin.com/in/russellsundby
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: